stemspantm serum-free expansion medium ii (STEMCELL Technologies Inc)
90
Structured Review
STEMCELL Technologies Inc
stemspantm serum-free expansion medium ii
Stemspantm Serum Free Expansion Medium Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stemspantm+serum-free+expansion+medium+ii/stemspantm+serum+free+expansion+medium++sfem+/pm40378432-47-5-10
Average 90 stars, based on 1 article reviews
Stemspantm Serum Free Expansion Medium Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stemspantm+serum-free+expansion+medium+ii/stemspantm+serum+free+expansion+medium++sfem+/pm40378432-47-5-10
Average 90 stars, based on 1 article reviews
stemspantm serum-free expansion medium ii - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Multiple Displacement Amplification:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Flow Cytometry:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with RNA Sequencing:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Cell Culture:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Isolation:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Concentration Assay:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Derivative Assay:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Clinical Proteomics:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Ex Vivo:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with Control:Article Title: Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target. Article Snippet: Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy with a low survival probability and limited therapeutic options.. Although galectin-1 (LGALS1) has been implicated in tumor cell survival and immune evasion in solid tumor, its role in AML is still unclear.. In this study, we found that LGALS1 presents prominent upregulation in AML patients at both mRNA and protein levels compared with the control samples. Article Title: An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche Article Snippet: After OB maturation, additional BM-MSCs, human umbilical vein ECs (Lonza), and Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Briefly, CD34+ cells derived from cord blood were cultured in StemSpanTM serum-free expansion medium II (STEMCELL Technologies, Vancouver, British Columbia, Canada) containing StemSpanTM CD34+ expansion supplement ( Article Title: Identification and interrogation of the gene regulatory network of CEBPA -double mutant acute myeloid leukemia Article Snippet: C/EBPA N/C -8 cells were cultured at the concentration of 1 × 10 6 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity. Article Snippet: Cells were cultured in StemSpanTM serum-free expansion medium II containing StemSpan erythroid expansion supplement ( Article Title: Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia Article Snippet: The Vybrant ® CFDA SE Cell Tracer lit (Thermo Fisher Scientific, Inc.) was used to distinguish between proliferating and non-proliferating cells, and Article Title: Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Article Snippet: Primary cell culture and isolation of hematopoietic stem/ progenitor cells C/EBPAN/C-8 cells were cultured at the concentration of 1 × 106 cell/mL in StemSpanTM Serum-Free Expansion Medium II (SFEMII) plus 10% StemSpanTM CD34+ Expansion Supplement and 175 nM Article Title: Patient-derived induced pluripotent stem cells with a MERTK mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential Article Snippet: PBMCs were cultured in StemSpanTM Serum-Free Expansion Medium II supplemented with |
